$ALLO Allogene Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allogene Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allogene Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Allogene Therapeutics, Inc. for free.
IRS Number: 823562771
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ALLO
Company Address: 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO 94080
Phone number: (212) 871-7920
Allogene Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Option Exercise | A | 25.76 | 28,015 | 721,666 | 28,015 | ||
| Jun 11 2021 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Sell | S | 25.05 | 9,969 | 249,723 | 236,182 | 246.2 K to 236.2 K (-4.05 %) | |
| Jun 11 2021 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Gift | G | 0.00 | 500,000 | 0 | 243,885 | 743.9 K to 243.9 K (-67.21 %) | |
| Jun 11 2021 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Grant | A | 0.00 | 16,498 | 0 | 743,885 | 727.4 K to 743.9 K (+2.27 %) | |
| May 26 2021 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Option Exercise | M | 18.22 | 27,410 | 499,410 | 541,190 | |
| May 26 2021 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Buy | M | 18.22 | 27,410 | 499,410 | 2,312,279 | 2.3 M to 2.3 M (+1.20 %) |
| May 25 2021 | ALLO | Allogene Therapeut ... | Belldegrun Arie | Option Exercise | M | 18.22 | 379,066 | 6,906,583 | 0 | ||
| May 25 2021 | ALLO | Allogene Therapeut ... | Belldegrun Arie | Buy | M | 18.22 | 379,066 | 6,906,583 | 583,034 | 204 K to 583 K (+185.85 %) | |
| Apr 16 2021 | ALLO | Allogene Therapeut ... | Bhavnagri Veer | General Counsel | Option Exercise | M | 2.27 | 10,000 | 22,700 | 142,300 | |
| Apr 16 2021 | ALLO | Allogene Therapeut ... | Bhavnagri Veer | General Counsel | Sell | S | 32.64 | 606 | 19,780 | 421,353 | 422 K to 421.4 K (-0.14 %) |
| Apr 16 2021 | ALLO | Allogene Therapeut ... | Bhavnagri Veer | General Counsel | Sell | S | 32.01 | 9,394 | 300,738 | 421,959 | 431.4 K to 422 K (-2.18 %) |
| Apr 16 2021 | ALLO | Allogene Therapeut ... | Bhavnagri Veer | General Counsel | Buy | M | 2.27 | 10,000 | 22,700 | 431,353 | 421.4 K to 431.4 K (+2.37 %) |
| Mar 30 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Option Exercise | A | 33.78 | 92,365 | 3,120,090 | 92,365 | |
| Mar 30 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Grant | A | 0.00 | 24,866 | 0 | 96,097 | 71.2 K to 96.1 K (+34.91 %) |
| Mar 17 2021 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Sell | S | 38.05 | 2,798 | 106,471 | 110,035 | 112.8 K to 110 K (-2.48 %) |